These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31427622)

  • 1. Lyso-Gb3 modulates the gut microbiota and decreases butyrate production.
    Aguilera-Correa JJ; Madrazo-Clemente P; Martínez-Cuesta MDC; Peláez C; Ortiz A; Sánchez-Niño MD; Esteban J; Requena T
    Sci Rep; 2019 Aug; 9(1):12010. PubMed ID: 31427622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model.
    Jabbarzadeh-Tabrizi S; Boutin M; Day TS; Taroua M; Schiffmann R; Auray-Blais C; Shen JS
    J Lipid Res; 2020 Nov; 61(11):1410-1423. PubMed ID: 32868283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Fabry disease-associated lyso-Gb
    Delprete C; Uhlig F; Caprini M; Hyland NP
    Am J Physiol Gastrointest Liver Physiol; 2024 Dec; 327(6):G810-G817. PubMed ID: 39404773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.
    Sanchez-Niño MD; Sanz AB; Carrasco S; Saleem MA; Mathieson PW; Valdivielso JM; Ruiz-Ortega M; Egido J; Ortiz A
    Nephrol Dial Transplant; 2011 Jun; 26(6):1797-802. PubMed ID: 20504837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb₃-related analogues in Fabry disease.
    Boutin M; Auray-Blais C
    Anal Chem; 2014 Apr; 86(7):3476-83. PubMed ID: 24634980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
    Tsukimura T; Shiga T; Saito K; Ogawa Y; Sakuraba H; Togawa T
    Mol Genet Metab Rep; 2021 Sep; 28():100773. PubMed ID: 34136356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease.
    Talbot A; Nicholls K; Fletcher JM; Fuller M
    Mol Genet Metab; 2017 Sep; 122(1-2):121-125. PubMed ID: 28847675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease.
    Taguchi A; Ishii S; Mikame M; Maruyama H
    Mol Genet Metab Rep; 2023 Mar; 34():100952. PubMed ID: 36624895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Usefulness of Lifetime Globotriaosylsphingosine Exposure at Diagnosis and Baseline Modified Disease Severity Score in Early-Diagnosed Patients With Fabry Disease.
    Hotta J; Jogu Y; Bamba H; Izumiya Y; Kudo M; Imai T; Sakuraba H; Hamazaki T; Seto T
    Cureus; 2024 May; 16(5):e61380. PubMed ID: 38947680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabry Disease Biomarkers: Analysis of Urinary Lyso-Gb3 and Seven Related Analogs Using Tandem Mass Spectrometry.
    Lavoie P; Boutin M; Abaoui M; Auray-Blais C
    Curr Protoc Hum Genet; 2016 Jul; 90():17.22.1-17.22.12. PubMed ID: 27367162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of total concentration of urinary globotriaosylsphingosine plus its analogues in the diagnosis of Fabry disease.
    Alharbi FJ; Baig S; Rambhatla SB; Vijapurapu R; Auray-Blais C; Boutin M; Steeds R; Wheeldon N; Dawson C; Geberhiwot T
    Clin Chim Acta; 2020 Jan; 500():120-127. PubMed ID: 31654629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients.
    Boutin M; Lavoie P; Abaoui M; Auray-Blais C
    Curr Protoc Hum Genet; 2016 Jul; 90():17.23.1-17.23.9. PubMed ID: 27367163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease.
    Nowak A; Mechtler T; Kasper DC; Desnick RJ
    Mol Genet Metab; 2017 Aug; 121(4):320-324. PubMed ID: 28663131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Lyso-Gb3 Suggests the R118C GLA Mutation Is a Pathological Fabry Variant.
    Talbot A; Nicholls K
    JIMD Rep; 2019; 45():95-98. PubMed ID: 30569317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyso-globotriaosylsphingosine induces endothelial dysfunction
    Hwang AR; Park S; Woo CH
    Korean J Physiol Pharmacol; 2023 May; 27(3):231-240. PubMed ID: 37078297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma globotriaosylsphingosine as a biomarker of Fabry disease.
    Togawa T; Kodama T; Suzuki T; Sugawara K; Tsukimura T; Ohashi T; Ishige N; Suzuki K; Kitagawa T; Sakuraba H
    Mol Genet Metab; 2010 Jul; 100(3):257-61. PubMed ID: 20409739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide.
    Jeon YJ; Jung N; Park JW; Park HY; Jung SC
    PLoS One; 2015; 10(8):e0136442. PubMed ID: 26291612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain.
    Choi L; Vernon J; Kopach O; Minett MS; Mills K; Clayton PT; Meert T; Wood JN
    Neurosci Lett; 2015 May; 594():163-8. PubMed ID: 25697597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients.
    Heywood WE; Doykov I; Spiewak J; Hallqvist J; Mills K; Nowak A
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2726-2735. PubMed ID: 31319156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
    Sueoka H; Aoki M; Tsukimura T; Togawa T; Sakuraba H
    PLoS One; 2015; 10(12):e0144958. PubMed ID: 26661087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.